...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

ryau1135,,,,,are you recieving any literature or voting documents for Zenith since buying OTC, if you do own the shares one would think these documents would be mailed to you?

Share
New Message
Please login to post a reply